<p>Health officials around the world are sounding the alarm on a highly infectious bacteria causing extensively drug-resistant infections. <em>Shigella</em>, which causes the infection known as shigellosis, is a genus of bacteria that results in gastrointestinal distress that ranges from uncomfortable to deadly, in adults and children. Global surveillance efforts on<em> Shigella</em> have identified outbreaks of strains that are extensively drug-resistant across the UK, US, and parts of Europe. How is the world dealing with this new superbug?</p>

<p>&nbsp;</p>

<p><strong>Guests</strong></p>

<p><strong>Lou Bourgeois, PhD:</strong> Johns Hopkins, Science Officer for Enteric and Diarrheal Diseases, PATH</p>

<p><strong>Gauri Godbole, MBBS, MD:</strong>&nbsp;UKHSA, Consultant Microbiologist and Parasitologist, Hospital for Tropical Diseases, University College London Hospitals, NHS</p>

<p><strong>Naemah Logan, MD:</strong> Medical Officer, Surveillance Epidemiologist, National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS), Centers for Disease Control and Prevention (CDC)</p>

<p><strong>Louise Francois Watkins, MD:</strong> Medical Officer, NARMS, Centers for Disease Control and Prevention: CDC</p>

<p>&nbsp;</p>

Podden och tillhörande omslagsbild på den här sidan tillhör CIDRAP. Innehållet i podden är skapat av CIDRAP och inte av, eller tillsammans med, Poddtoppen.